RN7SL383P

Across TCGA pan-cancer cohorts, RN7SL383P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RN7SL383P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RN7SL383P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL383P expression acts as an unfavorable survival marker.

BLCA, ESCA, and KIRP are the cancer types where RN7SL383P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	IV	0.074	0.599	<.001	54	view →
ESCA	OS	Tertile	All	0.276	0.543	.015	36	view →
KIRP	OS	Tertile	III,IV	0.268	0.808	.012	27	view →
PAAD	OS	Tertile	All	0.189	0.495	.033	18	view →
OV	DFS	Tertile	IV	0.160	0.469	.027	18	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
THCA	DFS	Tertile	All	0.405	0.874	<.001	9	view →
LGG	OS	Tertile	All	0.201	0.526	.025	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RN7SL383P–BLCA (OS)

Open the BLCA breakdown →